Professor
Prof. ElSayed Abdou Zaki KHAFAGY
الصيدلة Pharmacy AL-Kharj - Fharmacognosy20Published research
Overview
Prof. ElSayed Abdou Zaki KHAFAGY Faculty member in the field of الصيدلة College Pharmacy AL-Kharj At Prince Sattam bin Abdulaziz University, he contributes to supporting the educational and learning process by offering academic courses, participating in educational activities and programs, and supporting the development of students' skills and enhancing their knowledge in the field. الصيدلة
Academic qualifications
PhD in Pharmaceutics
Pharmacists - pharmacy
Kyoto University — Japan
2009
Master of Pharmaceuticals
Pharmacists - pharmacy
Suez Canal University, Egypt — Egypt
2003
Bachelor of Pharmaceuticals
Pharmacists - pharmacy
Suez Canal University, Egypt — Egypt
1997
Academic progression
Professor
الصيدلانيات - كلية الصيدلة بالخرج
2026
Associate Professor
الصيدلانيات - كلية الصيدلة بالخرج
2018
Research interests
• • Project 1: Evaluation and Improvement of Transmucosal Drug Absorption by Various Approaches.
• Project 2: Development of Biodrugs Delivery Systems for Non-parenteral Administration.
• Project 3: Applications of Nanotechnology in Biology and Medicine.
• Project 4: Development of Novel Brain Delivery Systems of Psychotropic Biodrugs.
I am currently pursuing the following research projects:
• Project 5: Oral Delivery of Macromolecular Therapies via Reversible Modulation of Intestinal Tight Junctions.
• Project 6: Development of 3D In Vitro Model of Blood-Brain Barrier in Layered Microfluidic Channels.
• Project 7: Improvement of CNS Delivery of Macromolcular Therapies Using CPPs into In Vitro Model of the Blood-Brain Barrier in Layered Microfluidic Channels.
• Project 8: Evaluation the Effect of Pseudomonas aeruginosa Elastase on the Integrity of Epithelial Monolayers.
• Project 9: Modulation of Intracellular Ca2+ Concentration in Brain Microvascular Endothelial Cells In Vitro by Acoustic Cavitation.
• Project 10: Evaluation of the Potential of CPPs in Inhibition of P-glycoprotein (P-gp) Activity by Everted Sac Model.
• Project 11: Development of Nasal Pegylated Biodrugs for Delivery Systems using Cell-Penetrating Peptides.
• Project 12: Development of Oral Delivery Systems for Biopharmaceuticals Based on Innovative CPPs Strategy.
• Project 13: Application of Simplex Lattice Design for Investigating the Effect of Formulation Variables on Critical Attributes of Fast Orodispersible Tablets.
• Project 14: Application of Quality by Design (QbD) Concept for Design and Optimization of Fast Orally Melting Tablets Using Suspension Spray Technique.
• Project 15: Development and Optimize Gastroretentive System Using Simplex Lattice Design for Investigating the Effect of Formulation Variables on Critical Attributes of Oral Tablets.
• Project 16: Enhancement of the therapeutic efficacy of natural plant products via formulation into nano-based drug delivery systems.
• Project 17: New strategies for tackling bacterial infection.
Published research
View all research (20)2023
Anticancer potentials of metformin loaded coconut oil nanoemulsion on MCF-7, HepG2 and HCT-116 cell lines
TAYLOR & FRANCIS LTD
Dual targeting multiwalled carbon nanotubes for improved neratinib delivery in breast cancer
ROYAL SOC CHEMISTRY
Ocular Delivery of Bimatoprost-Loaded Solid Lipid Nanoparticles for Effective Management of Glaucoma
MDPI
Piperine-Loaded In Situ Gel: Formulation, In Vitro Characterization, and Clinical Evaluation against Periodontitis
MDPI
In Vitro Cytotoxicity and In Vivo Antitumor Activity of Lipid Nanocapsules Loaded with Novel Pyridine Derivatives
MDPI
Analytical Methodologies for the Estimation of Oxazolidinone Antibiotics as Key Members of anti-MRSA Arsenal: A Decade in Review
TAYLOR & FRANCIS INC
Development of Tea Tree Oil Based Nanoemulgel Loaded with Azithromycin for Enhancing the Antibacterial Activity
MDPI
Coleus aromaticus Ethanolic Leaves Extract Mediates Inhibition of NF-?B Signaling Pathway in Lung Adenocarcinoma A549 Cells
MDPI
Diminishing the Pathogenesis of the Food-Borne Pathogen Serratia marcescens by Low Doses of Sodium Citrate
MDPI
Drug repositioning: doxazosin attenuates the virulence factors and biofilm formation in Gram-negative bacteria
SPRINGER
A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death
MDPI
Development and Characterization of Pullulan-Based Orodispersible Films of Iron
MDPI
Flavonol-Glycoside and Rare Triterpenoid Derivatives Isolated from Leaves of Combretum glutinosum Perr. Ex Dc. with In Vitro Cytotoxic Activity
MDPI
Clinical Resistant Strains of Enterococci and Their Correlation to Reduced Susceptibility to Biocides: Phenotypic and Genotypic Analysis of Macrolides, Lincosamides, and Streptogramins
MDPI
The flavonoid hesperidin methyl chalcone as a potential therapeutic agent for cancer therapy: Molecular docking, in vitro cytotoxicity, and in vivo antitumor activity
ELSEVIER
Ganetespib with Methotrexate Acts Synergistically to Impede NF-?B/p65 Signaling in Human Lung Cancer A549 Cells
MDPI
Antibiotic-Loaded Gold Nanoparticles: A Nano-Arsenal against ESBL Producer-Resistant Pathogens
MDPI
Development and Optimization of Erythromycin Loaded Transethosomes Cinnamon Oil Based Emulgel for Antimicrobial Efficiency
MDPI
Nano-Conversion of Ineffective Cephalosporins into Potent One against Resistant Clinical Uro-Pathogens via Gold Nanoparticles
MDPI
Tailoring of Novel Bile Salt Stabilized Vesicles for Enhanced Transdermal Delivery of Simvastatin: A New Therapeutic Approach against Inflammation
MDPI
Courses
15 Decision| Course code | Course Name |
|---|---|
| PHT 622 | DRUG STABILITY |
| PHT 627 | GOOD MANUFACTURING PRACTICE (GMP) OF PHARMACEUTICAL DOSAGE FORMS |
| PHT 630 | SEMINAR IN PHARMACEUTICS -1 |
| PHT 220 | Pharmaceutical Calculation |
| PHT 211 | Pharmaceutics-1 |
| PHT 431 | Sterile Dosage Form |
| PHT 632 | SCALE-UP TECHNIQUIES & PILOT PLANT |
| PHT 646 | RESEARCH PROJECT |
| PHT 623 | ADVANCED BIOPHARMACEUTICS |
| PHT 314 | Pharmaceutics-2 |
| PHT 614 | Physical Pharmacy & Preformulation Considerations |
| PHT 432 | Industrial Pharmacy |
| PHT 633 | REGULATORY AFFAIRS OF PHARMACEUTICAL DOSAGE FORMS |
| PHT 645 | REGISTERATION OF PHARMACEUTICAL DOSAGE FORMS |
| PHTR 495 | Research Project |
لا توجد نتائج مطابقة
Try another search term or clear the field to view all courses.
